A citation-based method for searching scientific literature

F Borovecki, L Lovrecic, J Zhou, H Jeong, F Then, H D Rosas, S M Hersch, P Hogarth, B Bouzou, R V Jensen, D Krainc. Proc Natl Acad Sci U S A 2005
Times Cited: 286







List of co-cited articles
684 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Analysis of potential transcriptomic biomarkers for Huntington's disease in peripheral blood.
Heike Runne, Alexandre Kuhn, Edward J Wild, Wirahpati Pratyaksha, Mark Kristiansen, Jeremy D Isaacs, Etienne Régulier, Mauro Delorenzi, Sarah J Tabrizi, Ruth Luthi-Carter. Proc Natl Acad Sci U S A 2007
99
24


Huntington's disease biomarker progression profile identified by transcriptome sequencing in peripheral blood.
Anastasios Mastrokolias, Yavuz Ariyurek, Jelle J Goeman, Erik van Duijn, Raymund A C Roos, Roos C van der Mast, GertJan B van Ommen, Johan T den Dunnen, Peter A C 't Hoen, Willeke M C van Roon-Mom. Eur J Hum Genet 2015
53
33

Regional and cellular gene expression changes in human Huntington's disease brain.
Angela Hodges, Andrew D Strand, Aaron K Aragaki, Alexandre Kuhn, Thierry Sengstag, Gareth Hughes, Lyn A Elliston, Cathy Hartog, Darlene R Goldstein, Doris Thu,[...]. Hum Mol Genet 2006
533
17

A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease.
Maria Björkqvist, Edward J Wild, Jenny Thiele, Aurelio Silvestroni, Ralph Andre, Nayana Lahiri, Elsa Raibon, Richard V Lee, Caroline L Benn, Denis Soulet,[...]. J Exp Med 2008
393
17

Transcriptional modulator H2A histone family, member Y (H2AFY) marks Huntington disease activity in man and mouse.
Yi Hu, Vanita Chopra, Raman Chopra, Joseph J Locascio, Zhixiang Liao, Hongliu Ding, Bin Zheng, Wayne R Matson, Robert J Ferrante, H Diana Rosas,[...]. Proc Natl Acad Sci U S A 2011
68
23

Beyond the brain: widespread pathology in Huntington's disease.
Jorien M M van der Burg, Maria Björkqvist, Patrik Brundin. Lancet Neurol 2009
222
14

Gene expression changes in blood as a putative biomarker for Huntington's disease.
Luca Lovrecic, Andrej Kastrin, Jan Kobal, Zvezdan Pirtosek, Dimitri Krainc, Borut Peterlin. Mov Disord 2009
23
52

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.
Aravind Subramanian, Pablo Tamayo, Vamsi K Mootha, Sayan Mukherjee, Benjamin L Ebert, Michael A Gillette, Amanda Paulovich, Scott L Pomeroy, Todd R Golub, Eric S Lander,[...]. Proc Natl Acad Sci U S A 2005
12


Mutant huntingtin fragmentation in immune cells tracks Huntington's disease progression.
Andreas Weiss, Ulrike Träger, Edward J Wild, Stephan Grueninger, Ruth Farmer, Christian Landles, Rachael I Scahill, Nayana Lahiri, Salman Haider, Douglas Macdonald,[...]. J Clin Invest 2012
89
11

Molecular markers of early Parkinson's disease based on gene expression in blood.
Clemens R Scherzer, Aron C Eklund, Lee J Morse, Zhixiang Liao, Joseph J Locascio, Daniel Fefer, Michael A Schwarzschild, Michael G Schlossmacher, Michael A Hauser, Jeffery M Vance,[...]. Proc Natl Acad Sci U S A 2007
328
9

Dysregulation of gene expression in the R6/2 model of polyglutamine disease: parallel changes in muscle and brain.
Ruth Luthi-Carter, Sarah A Hanson, Andrew D Strand, Donald A Bergstrom, Wanjoo Chun, Nikki L Peters, Annette M Woods, Edmond Y Chan, Charles Kooperberg, Dimitri Krainc,[...]. Hum Mol Genet 2002
297
9

Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration.
Libin Cui, Hyunkyung Jeong, Fran Borovecki, Christopher N Parkhurst, Naoko Tanese, Dimitri Krainc. Cell 2006
761
9

Transcriptional profiling of Alzheimer blood mononuclear cells by microarray.
Olivier C Maes, Suying Xu, Bo Yu, Howard M Chertkow, Eugenia Wang, Hyman M Schipper. Neurobiol Aging 2007
141
8


Microglial activation in presymptomatic Huntington's disease gene carriers.
Yen F Tai, Nicola Pavese, Alexander Gerhard, Sarah J Tabrizi, Roger A Barker, David J Brooks, Paola Piccini. Brain 2007
280
8

Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage.
Alexandre Kuhn, Darlene R Goldstein, Angela Hodges, Andrew D Strand, Thierry Sengstag, Charles Kooperberg, Kristina Becanovic, Mahmoud A Pouladi, Kirupa Sathasivam, Jang-Ho J Cha,[...]. Hum Mol Genet 2007
255
8

What have we learned from gene expression profiles in Huntington's disease?
Tamara Seredenina, Ruth Luthi-Carter. Neurobiol Dis 2012
101
8

Is human blood a good surrogate for brain tissue in transcriptional studies?
Chaochao Cai, Peter Langfelder, Tova F Fuller, Michael C Oldham, Rui Luo, Leonard H van den Berg, Roel A Ophoff, Steve Horvath. BMC Genomics 2010
77
10

Proteomic profiling of plasma in Huntington's disease reveals neuroinflammatory activation and biomarker candidates.
Annette Dalrymple, Edward J Wild, Richard Joubert, Kirupa Sathasivam, Maria Björkqvist, Asa Petersén, Graham S Jackson, Jeremy D Isaacs, Mark Kristiansen, Gillian P Bates,[...]. J Proteome Res 2007
154
8

Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data.
Sarah J Tabrizi, Rachael I Scahill, Gail Owen, Alexandra Durr, Blair R Leavitt, Raymund A Roos, Beth Borowsky, Bernhard Landwehrmeyer, Chris Frost, Hans Johnson,[...]. Lancet Neurol 2013
511
8

Transcriptional abnormalities in Huntington disease.
Katharine L Sugars, David C Rubinsztein. Trends Genet 2003
421
8

Huntington's disease: from molecular pathogenesis to clinical treatment.
Christopher A Ross, Sarah J Tabrizi. Lancet Neurol 2011
958
8

Increased oxidative damage and mitochondrial abnormalities in the peripheral blood of Huntington's disease patients.
Chiung-Mei Chen, Yih-Ru Wu, Mei-Ling Cheng, Jun-Liang Liu, Yu-May Lee, Po-Wei Lee, Bing-Wen Soong, Daniel Tsun-Yee Chiu. Biochem Biophys Res Commun 2007
159
8

Quantification of mutant huntingtin protein in cerebrospinal fluid from Huntington's disease patients.
Edward J Wild, Roberto Boggio, Douglas Langbehn, Nicola Robertson, Salman Haider, James R C Miller, Henrik Zetterberg, Blair R Leavitt, Rainer Kuhn, Sarah J Tabrizi,[...]. J Clin Invest 2015
131
8

Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis.
Lauren M Byrne, Filipe B Rodrigues, Kaj Blennow, Alexandra Durr, Blair R Leavitt, Raymund A C Roos, Rachael I Scahill, Sarah J Tabrizi, Henrik Zetterberg, Douglas Langbehn,[...]. Lancet Neurol 2017
173
8


Decreased expression of striatal signaling genes in a mouse model of Huntington's disease.
R Luthi-Carter, A Strand, N L Peters, S M Solano, Z R Hollingsworth, A S Menon, A S Frey, B S Spektor, E B Penney, G Schilling,[...]. Hum Mol Genet 2000
568
7

Comparative gene expression analysis of blood and brain provides concurrent validation of SELENBP1 up-regulation in schizophrenia.
Stephen J Glatt, Ian P Everall, William S Kremen, Jacques Corbeil, Roman Sásik, Negar Khanlou, Mark Han, Choong-Chin Liew, Ming T Tsuang. Proc Natl Acad Sci U S A 2005
237
7

Neuropathological classification of Huntington's disease.
J P Vonsattel, R H Myers, T J Stevens, R J Ferrante, E D Bird, E P Richardson. J Neuropathol Exp Neurol 1985
7

Huntington disease: natural history, biomarkers and prospects for therapeutics.
Christopher A Ross, Elizabeth H Aylward, Edward J Wild, Douglas R Langbehn, Jeffrey D Long, John H Warner, Rachael I Scahill, Blair R Leavitt, Julie C Stout, Jane S Paulsen,[...]. Nat Rev Neurol 2014
562
7

HTT-lowering reverses Huntington's disease immune dysfunction caused by NFκB pathway dysregulation.
Ulrike Träger, Ralph Andre, Nayana Lahiri, Anna Magnusson-Lind, Andreas Weiss, Stephan Grueninger, Chris McKinnon, Eva Sirinathsinghji, Shira Kahlon, Edith L Pfister,[...]. Brain 2014
103
7

Abnormal peripheral chemokine profile in Huntington's disease.
Edward Wild, Anna Magnusson, Nayana Lahiri, Ulrika Krus, Michael Orth, Sarah J Tabrizi, Maria Björkqvist. PLoS Curr 2011
68
10

Mutant huntingtin impairs immune cell migration in Huntington disease.
Wanda Kwan, Ulrike Träger, Dimitrios Davalos, Austin Chou, Jill Bouchard, Ralph Andre, Aaron Miller, Andreas Weiss, Flaviano Giorgini, Christine Cheah,[...]. J Clin Invest 2012
89
7

Chromosomal profiles of gene expression in Huntington's disease.
Alexander N Anderson, Federico Roncaroli, Angela Hodges, Manuel Deprez, Federico E Turkheimer. Brain 2008
40
15

Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice.
L Mangiarini, K Sathasivam, M Seller, B Cozens, A Harper, C Hetherington, M Lawton, Y Trottier, H Lehrach, S W Davies,[...]. Cell 1996
6

Increased apoptosis of Huntington disease lymphoblasts associated with repeat length-dependent mitochondrial depolarization.
A Sawa, G W Wiegand, J Cooper, R L Margolis, A H Sharp, J F Lawler, J T Greenamyre, S H Snyder, C A Ross. Nat Med 1999
458
6

Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data.
Sarah J Tabrizi, Ralf Reilmann, Raymund A C Roos, Alexandra Durr, Blair Leavitt, Gail Owen, Rebecca Jones, Hans Johnson, David Craufurd, Stephen L Hicks,[...]. Lancet Neurol 2012
367
6

Dysregulation of gene expression in primary neuron models of Huntington's disease shows that polyglutamine-related effects on the striatal transcriptome may not be dependent on brain circuitry.
Heike Runne, Etienne Régulier, Alexandre Kuhn, Diana Zala, Ozgun Gokce, Valérie Perrin, Beate Sick, Patrick Aebischer, Nicole Déglon, Ruth Luthi-Carter. J Neurosci 2008
74
8

Hsa-miR-34b is a plasma-stable microRNA that is elevated in pre-manifest Huntington's disease.
Philip Michael Gaughwin, Maciej Ciesla, Nayana Lahiri, Sarah J Tabrizi, Patrik Brundin, Maria Björkqvist. Hum Mol Genet 2011
132
6

The peripheral blood transcriptome dynamically reflects system wide biology: a potential diagnostic tool.
Choong-Chin Liew, Jun Ma, Hong-Chang Tang, Run Zheng, Adam A Dempsey. J Lab Clin Med 2006
446
6

A study of molecular changes relating to energy metabolism and cellular stress in people with Huntington's disease: looking for biomarkers.
Jolanta Krzysztoń-Russjan, Daniel Zielonka, Joanna Jackiewicz, Sylwia Kuśmirek, Irena Bubko, Aneta Klimberg, Jerzy T Marcinkowski, Elżbieta L Anuszewska. J Bioenerg Biomembr 2013
25
24

Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data.
Sarah J Tabrizi, Douglas R Langbehn, Blair R Leavitt, Raymund Ac Roos, Alexandra Durr, David Craufurd, Christopher Kennard, Stephen L Hicks, Nick C Fox, Rachael I Scahill,[...]. Lancet Neurol 2009
663
6

Common disease signatures from gene expression analysis in Huntington's disease human blood and brain.
Eleni Mina, Willeke van Roon-Mom, Kristina Hettne, Erik van Zwet, Jelle Goeman, Christian Neri, Peter A C 't Hoen, Barend Mons, Marco Roos. Orphanet J Rare Dis 2016
23
26

Detection of Huntington's disease decades before diagnosis: the Predict-HD study.
J S Paulsen, D R Langbehn, J C Stout, E Aylward, C A Ross, M Nance, M Guttman, S Johnson, M MacDonald, L J Beglinger,[...]. J Neurol Neurosurg Psychiatry 2008
554
6

Huntington's disease blood and brain show a common gene expression pattern and share an immune signature with Alzheimer's disease.
Davina J Hensman Moss, Michael D Flower, Kitty K Lo, James R C Miller, Gert-Jan B van Ommen, Peter A C 't Hoen, Timothy C Stone, Amelia Guinee, Douglas R Langbehn, Lesley Jones,[...]. Sci Rep 2017
29
20

Blood expression profiles for tuberous sclerosis complex 2, neurofibromatosis type 1, and Down's syndrome.
Yang Tang, Mark B Schapiro, David N Franz, Bonnie J Patterson, Francis J Hickey, Elizabeth K Schorry, Robert J Hopkin, Matthew Wylie, Tina Narayan, Tracy A Glauser,[...]. Ann Neurol 2004
65
7

8OHdG as a marker for Huntington disease progression.
Jeffrey D Long, Wayne R Matson, Andrew R Juhl, Blair R Leavitt, Jane S Paulsen. Neurobiol Dis 2012
45
11

Normal huntingtin function: an alternative approach to Huntington's disease.
Elena Cattaneo, Chiara Zuccato, Marzia Tartari. Nat Rev Neurosci 2005
451
5


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.